Investigating the prognostic value of non-coding RNAs in chronic lymphocytic leukemia: insights from a systematic review and meta-analysis Article Swipe
Amir Hossein Aghayan
,
Abolfazl Arab
,
Shadi Haddadi
,
Yasin Mirazimi
,
Ali Hosseinzadeh
,
Tayebeh Mohtashami
,
Amir Atashi
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s12885-025-15117-5
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s12885-025-15117-5
Background Non-coding RNA (ncRNA) expression dysregulation has been implicated in the prognosis of various cancers. Several mechanisms have been associated with altered expression of the ncRNAs with the progression of chronic lymphocytic leukemia (CLL). Based on the special properties that ncRNAs possess, including their stability, tissue specificity, and disease-associated dysregulation, a considerable amount of research has been conducted to identify their potential as non-invasive prognostic biomarkers. Methods A comprehensive search was conducted in WOS, Scopus, PubMed, Embase, and ProQuest, in accordance with PRISMA guidelines. Hazard ratios (HRs) were used to assess the prognostic value of ncRNA dysregulation in CLL. Risk of bias was evaluated with the QUIPS tool, and subgroup analyses were based on sample size and study quality. Publication bias was assessed using Egger’s, Begg’s, and Trim-and-Fill tests. Sensitivity analysis employed the leave-one-out method, and evidence certainty was graded using the modified GRADE framework. Results Our analysis included 4905 CLL patients. Dysregulated miRNAs were associated with shorter overall survival (OS) (HR: 2.41), progression-free survival (PFS) (HR: 1.82), and time to treatment (TTT) (HR: 2.39) in CLL patients. Dysregulation of lncRNAs was linked to poorer OS (HR: 2.76) and earlier TTT initiation (HR: 2.53). Additionally, dysregulation of circRNAs was associated with poorer OS (HR: 3.91). Conclusion Our comprehensive meta-analysis results showed that dysregulation of ncRNAs, including miRNAs, lncRNAs, and circRNAs, was associated with poor clinical outcomes in parameters such as OS, PFS, and TTT, identifying them as moderate prognostic markers for CLL patients.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1186/s12885-025-15117-5
- https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5
- OA Status
- gold
- References
- 78
- OpenAlex ID
- https://openalex.org/W4416070114
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416070114Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s12885-025-15117-5Digital Object Identifier
- Title
-
Investigating the prognostic value of non-coding RNAs in chronic lymphocytic leukemia: insights from a systematic review and meta-analysisWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-10Full publication date if available
- Authors
-
Amir Hossein Aghayan, Abolfazl Arab, Shadi Haddadi, Yasin Mirazimi, Ali Hosseinzadeh, Tayebeh Mohtashami, Amir AtashiList of authors in order
- Landing page
-
https://doi.org/10.1186/s12885-025-15117-5Publisher landing page
- PDF URL
-
https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
78Number of works referenced by this work
Full payload
| id | https://openalex.org/W4416070114 |
|---|---|
| doi | https://doi.org/10.1186/s12885-025-15117-5 |
| ids.doi | https://doi.org/10.1186/s12885-025-15117-5 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41214566 |
| ids.openalex | https://openalex.org/W4416070114 |
| fwci | |
| type | review |
| title | Investigating the prognostic value of non-coding RNAs in chronic lymphocytic leukemia: insights from a systematic review and meta-analysis |
| biblio.issue | 1 |
| biblio.volume | 25 |
| biblio.last_page | 1739 |
| biblio.first_page | 1739 |
| is_xpac | False |
| apc_list.value | 1790 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2195 |
| apc_paid.value | 1790 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2195 |
| language | en |
| locations[0].id | doi:10.1186/s12885-025-15117-5 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S192926780 |
| locations[0].source.issn | 1471-2407 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1471-2407 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Cancer |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | BioMed Central, Springer Nature |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Cancer |
| locations[0].landing_page_url | https://doi.org/10.1186/s12885-025-15117-5 |
| locations[1].id | pmid:41214566 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC cancer |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41214566 |
| locations[2].id | pmh:oai:doaj.org/article:19678c56dcb74a9b94358516a3bf733a |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | BMC Cancer, Vol 25, Iss 1, Pp 1-15 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/19678c56dcb74a9b94358516a3bf733a |
| locations[3].id | pmh:oai:europepmc.org:11412604 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12604295 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5092699787 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6843-9664 |
| authorships[0].author.display_name | Amir Hossein Aghayan |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I116768543 |
| authorships[0].affiliations[0].raw_affiliation_string | Student Research Committee, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[0].institutions[0].id | https://openalex.org/I116768543 |
| authorships[0].institutions[0].ror | https://ror.org/01xf7jb19 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I116768543 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | Zanjan University of Medical Sciences |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Amir Hossein Aghayan |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Student Research Committee, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[1].author.id | https://openalex.org/A5077552452 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0024-2937 |
| authorships[1].author.display_name | Abolfazl Arab |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I33103891 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran |
| authorships[1].institutions[0].id | https://openalex.org/I33103891 |
| authorships[1].institutions[0].ror | https://ror.org/04n4dcv16 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I33103891 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Ardabil University of Medical Sciences |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ali Arab |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran |
| authorships[2].author.id | https://openalex.org/A5113154875 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Shadi Haddadi |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I33103891 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran |
| authorships[2].institutions[0].id | https://openalex.org/I33103891 |
| authorships[2].institutions[0].ror | https://ror.org/04n4dcv16 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I33103891 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Ardabil University of Medical Sciences |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Shadi Haddadi |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran |
| authorships[3].author.id | https://openalex.org/A5092699786 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-5862-5893 |
| authorships[3].author.display_name | Yasin Mirazimi |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I116768543 |
| authorships[3].affiliations[0].raw_affiliation_string | Student Research Committee, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[3].institutions[0].id | https://openalex.org/I116768543 |
| authorships[3].institutions[0].ror | https://ror.org/01xf7jb19 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I116768543 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | Zanjan University of Medical Sciences |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yasin Mirazimi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Student Research Committee, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran |
| authorships[4].author.id | https://openalex.org/A5051356798 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-0055-9408 |
| authorships[4].author.display_name | Ali Hosseinzadeh |
| authorships[4].countries | IR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I71736372 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran |
| authorships[4].institutions[0].id | https://openalex.org/I71736372 |
| authorships[4].institutions[0].ror | https://ror.org/023crty50 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I71736372 |
| authorships[4].institutions[0].country_code | IR |
| authorships[4].institutions[0].display_name | Shahroud University of Medical Sciences |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ali Hosseinzadeh |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran |
| authorships[5].author.id | https://openalex.org/A5109256700 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0034-233X |
| authorships[5].author.display_name | Tayebeh Mohtashami |
| authorships[5].countries | IR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I71736372 |
| authorships[5].affiliations[0].raw_affiliation_string | Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran |
| authorships[5].institutions[0].id | https://openalex.org/I71736372 |
| authorships[5].institutions[0].ror | https://ror.org/023crty50 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I71736372 |
| authorships[5].institutions[0].country_code | IR |
| authorships[5].institutions[0].display_name | Shahroud University of Medical Sciences |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Tayebeh Mohtashami |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran |
| authorships[6].author.id | https://openalex.org/A5008190274 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3889-5642 |
| authorships[6].author.display_name | Amir Atashi |
| authorships[6].countries | IR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I71736372 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran |
| authorships[6].institutions[0].id | https://openalex.org/I71736372 |
| authorships[6].institutions[0].ror | https://ror.org/023crty50 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I71736372 |
| authorships[6].institutions[0].country_code | IR |
| authorships[6].institutions[0].display_name | Shahroud University of Medical Sciences |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Amir Atashi |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-10T00:00:00 |
| display_name | Investigating the prognostic value of non-coding RNAs in chronic lymphocytic leukemia: insights from a systematic review and meta-analysis |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T10:03:05.253647 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s12885-025-15117-5 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S192926780 |
| best_oa_location.source.issn | 1471-2407 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1471-2407 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Cancer |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | BioMed Central, Springer Nature |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Cancer |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s12885-025-15117-5 |
| primary_location.id | doi:10.1186/s12885-025-15117-5 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S192926780 |
| primary_location.source.issn | 1471-2407 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1471-2407 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Cancer |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | BioMed Central, Springer Nature |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-15117-5 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Cancer |
| primary_location.landing_page_url | https://doi.org/10.1186/s12885-025-15117-5 |
| publication_date | 2025-11-10 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2790385276, https://openalex.org/W4323314897, https://openalex.org/W3204288598, https://openalex.org/W2516651263, https://openalex.org/W4396973142, https://openalex.org/W3193202599, https://openalex.org/W3085328657, https://openalex.org/W3131553759, https://openalex.org/W4315436171, https://openalex.org/W4283027006, https://openalex.org/W2958863468, https://openalex.org/W2027609340, https://openalex.org/W2811212358, https://openalex.org/W2392898792, https://openalex.org/W2041081193, https://openalex.org/W2063123633, https://openalex.org/W4306385659, https://openalex.org/W4313488537, https://openalex.org/W2908061676, https://openalex.org/W3031099313, https://openalex.org/W3007962143, https://openalex.org/W2931787987, https://openalex.org/W4322773921, https://openalex.org/W4312113004, https://openalex.org/W2560438049, https://openalex.org/W2088095316, https://openalex.org/W2942478007, https://openalex.org/W2047586716, https://openalex.org/W2088723100, https://openalex.org/W2468586217, https://openalex.org/W4385330305, https://openalex.org/W2886507032, https://openalex.org/W2779230345, https://openalex.org/W2809508640, https://openalex.org/W2804021129, https://openalex.org/W2885439941, https://openalex.org/W4316371454, https://openalex.org/W2060013333, https://openalex.org/W1942842744, https://openalex.org/W2999929450, https://openalex.org/W2163819674, https://openalex.org/W2068004842, https://openalex.org/W2158214783, https://openalex.org/W2802706533, https://openalex.org/W1570248137, https://openalex.org/W1986613820, https://openalex.org/W3099756113, https://openalex.org/W2090635221, https://openalex.org/W1993636685, https://openalex.org/W2280332147, https://openalex.org/W2947648330, https://openalex.org/W2007430145, https://openalex.org/W2590889937, https://openalex.org/W2801509148, https://openalex.org/W2516692944, https://openalex.org/W4366998609, https://openalex.org/W4294599984, https://openalex.org/W2808219623, https://openalex.org/W4229021925, https://openalex.org/W2980132232, https://openalex.org/W4387564542, https://openalex.org/W2070651992, https://openalex.org/W4205529197, https://openalex.org/W4385606547, https://openalex.org/W3047193071, https://openalex.org/W2957955341, https://openalex.org/W3158209645, https://openalex.org/W4308772807, https://openalex.org/W3187937142, https://openalex.org/W3036950099, https://openalex.org/W4388539585, https://openalex.org/W2798112566, https://openalex.org/W3036171155, https://openalex.org/W4386190232, https://openalex.org/W4383032646, https://openalex.org/W4400187757, https://openalex.org/W4399900888, https://openalex.org/W3007336926 |
| referenced_works_count | 78 |
| abstract_inverted_index.A | 68 |
| abstract_inverted_index.a | 51 |
| abstract_inverted_index.OS | 186, 203 |
| abstract_inverted_index.as | 63, 230, 237 |
| abstract_inverted_index.in | 10, 73, 80, 98, 176, 227 |
| abstract_inverted_index.of | 13, 24, 30, 54, 95, 101, 180, 197, 214 |
| abstract_inverted_index.on | 36, 114 |
| abstract_inverted_index.to | 59, 90, 171, 184 |
| abstract_inverted_index.CLL | 151, 177, 242 |
| abstract_inverted_index.OS, | 231 |
| abstract_inverted_index.Our | 147, 207 |
| abstract_inverted_index.RNA | 3 |
| abstract_inverted_index.TTT | 191 |
| abstract_inverted_index.and | 48, 78, 109, 117, 127, 136, 169, 189, 219, 233 |
| abstract_inverted_index.for | 241 |
| abstract_inverted_index.has | 7, 56 |
| abstract_inverted_index.the | 11, 25, 28, 37, 92, 106, 133, 142 |
| abstract_inverted_index.was | 71, 103, 122, 139, 182, 199, 221 |
| abstract_inverted_index.(HR: | 162, 167, 174, 187, 193, 204 |
| abstract_inverted_index.(OS) | 161 |
| abstract_inverted_index.4905 | 150 |
| abstract_inverted_index.CLL. | 99 |
| abstract_inverted_index.PFS, | 232 |
| abstract_inverted_index.Risk | 100 |
| abstract_inverted_index.TTT, | 234 |
| abstract_inverted_index.WOS, | 74 |
| abstract_inverted_index.been | 8, 19, 57 |
| abstract_inverted_index.bias | 102, 121 |
| abstract_inverted_index.have | 18 |
| abstract_inverted_index.poor | 224 |
| abstract_inverted_index.size | 116 |
| abstract_inverted_index.such | 229 |
| abstract_inverted_index.that | 40, 212 |
| abstract_inverted_index.them | 236 |
| abstract_inverted_index.time | 170 |
| abstract_inverted_index.used | 89 |
| abstract_inverted_index.were | 88, 112, 155 |
| abstract_inverted_index.with | 21, 27, 82, 105, 157, 201, 223 |
| abstract_inverted_index.(HRs) | 87 |
| abstract_inverted_index.(PFS) | 166 |
| abstract_inverted_index.(TTT) | 173 |
| abstract_inverted_index.2.39) | 175 |
| abstract_inverted_index.2.76) | 188 |
| abstract_inverted_index.Based | 35 |
| abstract_inverted_index.GRADE | 144 |
| abstract_inverted_index.QUIPS | 107 |
| abstract_inverted_index.based | 113 |
| abstract_inverted_index.ncRNA | 96 |
| abstract_inverted_index.study | 118 |
| abstract_inverted_index.their | 44, 61 |
| abstract_inverted_index.tool, | 108 |
| abstract_inverted_index.using | 124, 141 |
| abstract_inverted_index.value | 94 |
| abstract_inverted_index.(CLL). | 34 |
| abstract_inverted_index.1.82), | 168 |
| abstract_inverted_index.2.41), | 163 |
| abstract_inverted_index.2.53). | 194 |
| abstract_inverted_index.3.91). | 205 |
| abstract_inverted_index.Hazard | 85 |
| abstract_inverted_index.PRISMA | 83 |
| abstract_inverted_index.amount | 53 |
| abstract_inverted_index.assess | 91 |
| abstract_inverted_index.graded | 140 |
| abstract_inverted_index.linked | 183 |
| abstract_inverted_index.miRNAs | 154 |
| abstract_inverted_index.ncRNAs | 26, 41 |
| abstract_inverted_index.poorer | 185, 202 |
| abstract_inverted_index.ratios | 86 |
| abstract_inverted_index.sample | 115 |
| abstract_inverted_index.search | 70 |
| abstract_inverted_index.showed | 211 |
| abstract_inverted_index.tests. | 129 |
| abstract_inverted_index.tissue | 46 |
| abstract_inverted_index.(ncRNA) | 4 |
| abstract_inverted_index.Embase, | 77 |
| abstract_inverted_index.Methods | 67 |
| abstract_inverted_index.PubMed, | 76 |
| abstract_inverted_index.Results | 146 |
| abstract_inverted_index.Scopus, | 75 |
| abstract_inverted_index.Several | 16 |
| abstract_inverted_index.altered | 22 |
| abstract_inverted_index.chronic | 31 |
| abstract_inverted_index.earlier | 190 |
| abstract_inverted_index.lncRNAs | 181 |
| abstract_inverted_index.markers | 240 |
| abstract_inverted_index.method, | 135 |
| abstract_inverted_index.miRNAs, | 217 |
| abstract_inverted_index.ncRNAs, | 215 |
| abstract_inverted_index.overall | 159 |
| abstract_inverted_index.results | 210 |
| abstract_inverted_index.shorter | 158 |
| abstract_inverted_index.special | 38 |
| abstract_inverted_index.various | 14 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.analyses | 111 |
| abstract_inverted_index.analysis | 131, 148 |
| abstract_inverted_index.assessed | 123 |
| abstract_inverted_index.cancers. | 15 |
| abstract_inverted_index.circRNAs | 198 |
| abstract_inverted_index.clinical | 225 |
| abstract_inverted_index.employed | 132 |
| abstract_inverted_index.evidence | 137 |
| abstract_inverted_index.identify | 60 |
| abstract_inverted_index.included | 149 |
| abstract_inverted_index.leukemia | 33 |
| abstract_inverted_index.lncRNAs, | 218 |
| abstract_inverted_index.moderate | 238 |
| abstract_inverted_index.modified | 143 |
| abstract_inverted_index.outcomes | 226 |
| abstract_inverted_index.possess, | 42 |
| abstract_inverted_index.quality. | 119 |
| abstract_inverted_index.research | 55 |
| abstract_inverted_index.subgroup | 110 |
| abstract_inverted_index.survival | 160, 165 |
| abstract_inverted_index.Begg’s, | 126 |
| abstract_inverted_index.ProQuest, | 79 |
| abstract_inverted_index.certainty | 138 |
| abstract_inverted_index.circRNAs, | 220 |
| abstract_inverted_index.conducted | 58, 72 |
| abstract_inverted_index.evaluated | 104 |
| abstract_inverted_index.including | 43, 216 |
| abstract_inverted_index.patients. | 152, 178, 243 |
| abstract_inverted_index.potential | 62 |
| abstract_inverted_index.prognosis | 12 |
| abstract_inverted_index.treatment | 172 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 206 |
| abstract_inverted_index.Egger’s, | 125 |
| abstract_inverted_index.Non-coding | 2 |
| abstract_inverted_index.accordance | 81 |
| abstract_inverted_index.associated | 20, 156, 200, 222 |
| abstract_inverted_index.expression | 5, 23 |
| abstract_inverted_index.framework. | 145 |
| abstract_inverted_index.implicated | 9 |
| abstract_inverted_index.initiation | 192 |
| abstract_inverted_index.mechanisms | 17 |
| abstract_inverted_index.parameters | 228 |
| abstract_inverted_index.prognostic | 65, 93, 239 |
| abstract_inverted_index.properties | 39 |
| abstract_inverted_index.stability, | 45 |
| abstract_inverted_index.Publication | 120 |
| abstract_inverted_index.Sensitivity | 130 |
| abstract_inverted_index.biomarkers. | 66 |
| abstract_inverted_index.guidelines. | 84 |
| abstract_inverted_index.identifying | 235 |
| abstract_inverted_index.lymphocytic | 32 |
| abstract_inverted_index.progression | 29 |
| abstract_inverted_index.Dysregulated | 153 |
| abstract_inverted_index.considerable | 52 |
| abstract_inverted_index.non-invasive | 64 |
| abstract_inverted_index.specificity, | 47 |
| abstract_inverted_index.Additionally, | 195 |
| abstract_inverted_index.Dysregulation | 179 |
| abstract_inverted_index.Trim-and-Fill | 128 |
| abstract_inverted_index.comprehensive | 69, 208 |
| abstract_inverted_index.dysregulation | 6, 97, 196, 213 |
| abstract_inverted_index.leave-one-out | 134 |
| abstract_inverted_index.meta-analysis | 209 |
| abstract_inverted_index.dysregulation, | 50 |
| abstract_inverted_index.progression-free | 164 |
| abstract_inverted_index.disease-associated | 49 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5008190274 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I71736372 |
| citation_normalized_percentile |